UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 0.5 um Flash Technology suitable for Low Voltage Embedded Applications

27th European Solid-State Device Research Conference, 1997, p.260-263

1997

Volltextzugriff (PDF)

1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1094-P: Short-Acting Exenatide and Markers of Cardiovascular Disease in Type 1 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Trial

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

110: Real-world outcomes in cystic fibrosis telehealth clinical care during the COVID-19 pandemic

Journal of cystic fibrosis, 2021-11, Vol.20, p.S55-S56

2021

Volltextzugriff (PDF)

14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION

Leukemia research, 2015-04, Vol.39, p.S5-S6

2015

Volltextzugriff (PDF)

18 - Prognostic Significance of Serial Molecular Annotation in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (SAML)

Leukemia research, 2017-04, Vol.55, p.S10-S10

2017

Volltextzugriff (PDF)

1999, Volume 33, Pages 3927−3928 Comment on “In Situ Measurements of Chlorinated Hydrocarbons in the Water Column off the Palos Verdes Peninsula, California”

Environmental science & technology, 2000-07, Vol.34 (13), p.2878-2878

2000

Volltextzugriff (PDF)

[2,3]-Wittig rearrangements of (trimethylsilyl)methyl allyl ethers

Tetrahedron letters, 1996-04, Vol.37 (14), p.2403-2404

1996

Volltextzugriff (PDF)

2-D inner-shelf current observations from a single VHF WEllen RAdar (WERA) station

2011 IEEE/OES 10th Current, Waves and Turbulence Measurements (CWTM), 2011, p.57-65

2011

Volltextzugriff (PDF)

217 DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE

Leukemia research, 2015-04, Vol.39, p.S109-S109

2015

Volltextzugriff (PDF)

24 - Impact of Gene Mutations on Response to Lenalidomide and OS in Lower-Risk Non-Del(5Q) MDS Patients Ineligible/Refractory to Erythropoiesis-Stimulating Agents (ESAS)

Leukemia research, 2017-04, Vol.55, p.S14-S14

2017

Volltextzugriff (PDF)

A 25-ns low-power full-CMOS 1-Mbit (128 K8) SRAM

IEEE journal of solid-state circuits, 1988-10, Vol.23 (5), p.1078-1084

1988

Volltextzugriff (PDF)

27 - The S100A9-FTO Axis Directs Genetic Instability in Myelodysplastic Syndromes (MDS)

Leukemia research, 2017-04, Vol.55, p.S16-S16

2017

Volltextzugriff (PDF)

276 Outcome of azacitidine treatment of patients with therapy related myelodysplastic syndrome

Leukemia research, 2011, Vol.35, p.S108-S109

2011

Volltextzugriff (PDF)

28 - Novel Role of S100A9-Induced Overexpression of PD-1/PD-L1 in HSPC and MDSC Contribute to Ineffective Hematopoiesis in MDS

Leukemia research, 2017-04, Vol.55, p.S17-S17

2017

Volltextzugriff (PDF)

286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS

Leukemia research, 2015-04, Vol.39, p.S142-S143

2015

Volltextzugriff (PDF)

2D-MoS2 goes 3D: transferring optoelectronic properties of 2D MoS2 to a large-area thin film

NPJ 2D materials and applications, 2021-07, Vol.5 (1), p.1-10, Article 64

2021

Volltextzugriff (PDF)

[ 3 H]Dopamine Labeling of D 3 Dopaminergic Sites in Human, Rat, and Calf Brain

Journal of neurochemistry, 1982-11, Vol.39 (5), p.1363-1373

1982

Volltextzugriff (PDF)

32 ACTIVATION OF REDOX-SENSITIVE INFLAMMASOMES UNDERLIES THE BIOLOGICAL PHENOTYPE OF MYELODYSPLASTIC SYNDROMES

Leukemia research, 2015-04, Vol.39, p.S14-S14

2015

Volltextzugriff (PDF)

320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM

Leukemia research, 2015-04, Vol.39, p.S158-S159

2015

Volltextzugriff (PDF)

39 Myeloid-derived suppressor cells (MDSC) are effectors of bone marrow suppression in lower risk myelodysplastic syndromes (MDS)

Leukemia research, 2011, Vol.35, p.S13-S13

2011

Volltextzugriff (PDF)

[3H]Dopamine Labeling of D3 Dopaminergic Sites in Human, Rat, and Calf Brain

Journal of neurochemistry, 1982-11, Vol.39 (5), p.1363-1373

1982

Volltextzugriff (PDF)

4 Controlling the “fate” of T cells in MDS

Leukemia research, 2009-05, Vol.33, p.S1-S2

2009

Volltextzugriff (PDF)

46 - Robust Patient-Derived Xenografts (PDX) Capture the Disease Fidelity of Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)

Leukemia research, 2017-04, Vol.55, p.S31-S32

2017

Volltextzugriff (PDF)

48 - Chromosomal Aberrations in Therapy-Related Myelodysplastic Syndromes – Relations to Primary Disease, Therapy and Prognostic Significance

Leukemia research, 2017-04, Vol.55, p.S32-S33

2017

Volltextzugriff (PDF)

1 – 25 von 2.573

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.164)
Mit Volltextzugriff
(2.181)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.400)
Life Sciences & Biomedicine
(759)
Physical Sciences
(543)
Humans
(525)
Male
(363)
Physics
(330)
Technology
(328)
Female
(322)
Middle Aged
(226)
Materials Science
(213)
Biological And Medical Sciences
(209)
Chemistry
(202)
Exact Sciences And Technology
(201)
Adult
(195)
Aged
(195)
Materials Science, Multidisciplinary
(184)
Animals
(179)
Physics, Applied
(160)
Social Sciences
(159)
Medical Sciences
(155)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(108)
Journal Of The American Oil Chemists' Society
(96)
The European Physical Journal. C, Particles And Fields
(59)
Journal Of Clinical Oncology
(50)
Leukemia Research
(44)
Leukemia
(33)
Marine Geology
(31)
Endocrinology
(30)
Angewandte Chemie
(28)
Cheminform
(26)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A 0.5 um Flash Technology suitable for Low Voltage Embedded Applications

1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial

1094-P: Short-Acting Exenatide and Markers of Cardiovascular Disease in Type 1 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Trial

110: Real-world outcomes in cystic fibrosis telehealth clinical care during the COVID-19 pandemic

14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION

18 - Prognostic Significance of Serial Molecular Annotation in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (SAML)

1999, Volume 33, Pages 3927−3928 Comment on “In Situ Measurements of Chlorinated Hydrocarbons in the Water Column off the Palos Verdes Peninsula, California”

[2,3]-Wittig rearrangements of (trimethylsilyl)methyl allyl ethers

2-D inner-shelf current observations from a single VHF WEllen RAdar (WERA) station

217 DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE

24 - Impact of Gene Mutations on Response to Lenalidomide and OS in Lower-Risk Non-Del(5Q) MDS Patients Ineligible/Refractory to Erythropoiesis-Stimulating Agents (ESAS)

A 25-ns low-power full-CMOS 1-Mbit (128 K8) SRAM

27 - The S100A9-FTO Axis Directs Genetic Instability in Myelodysplastic Syndromes (MDS)

276 Outcome of azacitidine treatment of patients with therapy related myelodysplastic syndrome

28 - Novel Role of S100A9-Induced Overexpression of PD-1/PD-L1 in HSPC and MDSC Contribute to Ineffective Hematopoiesis in MDS

286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS

2D-MoS2 goes 3D: transferring optoelectronic properties of 2D MoS2 to a large-area thin film

[ 3 H]Dopamine Labeling of D 3 Dopaminergic Sites in Human, Rat, and Calf Brain

32 ACTIVATION OF REDOX-SENSITIVE INFLAMMASOMES UNDERLIES THE BIOLOGICAL PHENOTYPE OF MYELODYSPLASTIC SYNDROMES

320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM

39 Myeloid-derived suppressor cells (MDSC) are effectors of bone marrow suppression in lower risk myelodysplastic syndromes (MDS)

[3H]Dopamine Labeling of D3 Dopaminergic Sites in Human, Rat, and Calf Brain

4 Controlling the “fate” of T cells in MDS

46 - Robust Patient-Derived Xenografts (PDX) Capture the Disease Fidelity of Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)

48 - Chromosomal Aberrations in Therapy-Related Myelodysplastic Syndromes – Relations to Primary Disease, Therapy and Prognostic Significance

Suchergebnisse filtern